Clinical Trials Browser

Phase 2 × Active not recruiting × Population Groups × Clear all

NCT05363280 2025-09-23

Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC

Phase 2 Active not recruiting

Small Cell Lung Carcinoma